Nitya G. Ray

Nitya G. Ray is a declared insider at 2 companies (senior executive); the most frequent names are CytoDyn Inc. and Actinium Pharmaceuticals, Inc. The record holds 21 filings, for trades running from 2 August 2017 to 15 November 2022.

On the market, this insider has only ever bought: 1 purchase, €6,328 in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 19 share grants.

Most recently, on 17 November 2022, the filings show a share grant in CytoDyn Inc. The latest purchase dates back some time: it was published 3,367 days ago, on 4 August 2017. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.